A bill in California to prohibit drug manufacturer conditions on 340B pricing and pharmacy benefit manager discrimination against 340B covered entities died in a state Assembly committee on Tuesday.
The state Senate voted 24-9 to pass the bill, SB-939, on May 23, sending it to the legislature’s lower chamber for consideration. The bill’s lead author, state Senate Health Committee Chair Richard Pan (D), asked the state Assembly Health Committee to cancel a June 28 hearing on the bill, scuttling it for this year’s legislative session. 340B Report asked Pan by email early this morning Eastern time why he sought the cancellation.
A bill in California to prohibit drug manufacturer conditions on 340B pricing and pharmacy benefit manager discrimination against 340B covered entities died in a state Assembly committee on Tuesday.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
